We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

970 hedge funds and large institutions have $46B invested in Thermo Fisher Scientific in 2015 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 380 increasing their positions, 337 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more call options, than puts

Call options by funds: $184M | Put options by funds: $157M

13% more repeat investments, than reductions

Existing positions increased: 380 | Existing positions reduced: 337

1.15% more ownership

Funds ownership: 88.8%89.95% (+1.1%)

5% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 66

1% more capital invested

Capital invested by funds: $45.8B → $46B (+$256M)

0% less funds holding

Funds holding: 974970 (-4)

1% less funds holding in top 10

Funds holding in top 10: 7069 (-1)

Holders
970
Holders Change
-4
Holders Change %
-0.41%
% of All Funds
27.08%
Holding in Top 10
69
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-1.43%
% of All Funds
1.93%
New
69
Increased
380
Reduced
337
Closed
66
Calls
$184M
Puts
$157M
Net Calls
+$27.2M
Net Calls Change
-$118M
Name Holding Trade Value Shares
Change
Change in
Stake
FWCM
776
Ferguson Wellman Capital Management
Oregon
$338K
RCP
777
Rothschild Capital Partners
New York
$336K
WPW
778
Waldron Private Wealth
Pennsylvania
$336K +$15.4K +118 +4%
W
779
Wealthfront
California
$333K +$84.6K +649 +31%
BFEC
780
Benjamin F. Edwards & Company
Missouri
$332K
DBG
781
De Burlo Group
Massachusetts
$330K
SOAMC
782
Spirit of America Management Corp
New York
$330K
PAI
783
Pittenger & Anderson Inc
Nebraska
$328K
PTC
784
Private Trust Company
Ohio
$328K +$54.6K +419 +18%
PAIA
785
Park Avenue Institutional Advisers
New York
$324K -$3.78K -29 -1%
BCB
786
Brian C. Broderick
$318K
CPS
787
Counsel Portfolio Services
Ontario, Canada
$318K
AI
788
Atria Investments
North Carolina
$318K +$21.5K +165 +7%
BCM
789
Bluefin Capital Management
New York
$318K +$339K +2,600 New
PFM
790
Parsec Financial Management
North Carolina
$317K +$88.3K +678 +35%
RMDI
791
R.M. Davis Inc
Maine
$317K +$338K +2,593 New
OIA
792
Optimum Investment Advisors
Illinois
$316K +$337K +2,585 New
PCM
793
Prelude Capital Management
New York
$314K -$632K -4,848 -65%
QCG
794
Quadrant Capital Group
Ohio
$313K
CSS
795
Cubist Systematic Strategies
Connecticut
$312K +$18.8K +144 +6%
VWM
796
Vector Wealth Management
Minnesota
$306K -$6.64K -51 -2%
NIM
797
Northeast Investment Management
Massachusetts
$306K +$326K +2,506 New
KFA
798
Kelleher Financial Advisors
New York
$305K
ARMT
799
Amica Retiree Medical Trust
Rhode Island
$304K
CCS
800
Crosspoint Capital Strategies
California
$302K -$46.1K -354 -13%

TMO Hedge Fund Activity: Q3 2015 in Review

970 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2015, worth a combined $46B — up 0.56% from $45.8B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new TMO positions and 66 closed out — a net gain of 3 holders — while 380 added to existing stakes and 337 trimmed.

The largest buyer was Longview Partners, opening a new position worth an estimated $668M. The largest seller was Temasek Holdings, cutting an estimated $309M.

  • 970 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2015, down from 974 in Q2 2015.
  • Funds reported $46B of Thermo Fisher Scientific stock for Q3 2015, up 0.56% quarter-over-quarter.
  • 69 funds opened new Thermo Fisher Scientific positions in Q3 2015 and 66 closed out, a net change of +3 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2015 was Longview Partners, an estimated $668M added.
  • The largest Thermo Fisher Scientific seller in Q3 2015 was Temasek Holdings, an estimated $309M sold.

Based on aggregated 13F filings for Q3 2015.